Xie Qiang, Zeng Jun, Zheng Yongtao, Li Tianwen, Ren Junwei, Chen Kezhu, Zhang Quan, Xie Rong, Xu Feng, Zhu Jianhong
Fudan University Huashan Hospital, Department of Neurosurgery, National Center for Neurological Disorders, National Key Laboratory for Medical Neurobiology, Shanghai Key Laboratory of Brain Function and Regeneration, Institutes of Brain Science, MOE Frontiers Center for Brain Science, Shanghai Medical College-Fudan University, 12 Wulumuqi Zhong Rd., Shanghai 200040, China.
Oxid Med Cell Longev. 2021 Nov 20;2021:1006636. doi: 10.1155/2021/1006636. eCollection 2021.
Mitochondrial dysfunctions play a pivotal role in cerebral ischemia-reperfusion (I/R) injury. Although mitochondrial transplantation has been recently explored for the treatment of cerebral I/R injury, the underlying mechanisms and fate of transplanted mitochondria are still poorly understood.
Mitochondrial morphology and function were assessed by fluorescent staining, electron microscopy, JC-1, PCR, mitochondrial stress testing, and metabolomics. Therapeutic effects of mitochondria were evaluated by cell viability, reactive oxygen species (ROS), and apoptosis levels in a cellular hypoxia-reoxygenation model. Rat middle cerebral artery occlusion model was applied to assess the mitochondrial therapy in vivo. Transcriptomics was performed to explore the underlying mechanisms. Mitochondrial fate tracking was implemented by a variety of fluorescent labeling methods.
Neuro-2a (N2a) cell-derived mitochondria had higher mitochondrial membrane potential, more active oxidative respiration capacity, and less mitochondrial DNA copy number. Exogenous mitochondrial transplantation increased cellular viability in an oxygen-dependent manner, decreased ROS and apoptosis levels, improved neurobehavioral deficits, and reduced infarct size. Transcriptomic data showed that the differential gene enrichment pathways are associated with metabolism, especially lipid metabolism. Mitochondrial tracking indicated specific parts of the exogenous mitochondria fused with the mitochondria of the host cell, and others were incorporated into lysosomes. This process occurred at the beginning of internalization and its efficiency is related to intercellular connection.
Mitochondrial transplantation may attenuate cerebral I/R injury. The mechanism may be related to mitochondrial component separation, altering cellular metabolism, reducing ROS, and apoptosis in an oxygen-dependent manner. The way of isolated mitochondrial transfer into the cell may be related to intercellular connection.
线粒体功能障碍在脑缺血再灌注(I/R)损伤中起关键作用。尽管最近已探索线粒体移植用于治疗脑I/R损伤,但其潜在机制以及移植线粒体的命运仍知之甚少。
通过荧光染色、电子显微镜、JC-1、聚合酶链反应、线粒体应激测试和代谢组学评估线粒体形态和功能。在细胞缺氧复氧模型中,通过细胞活力、活性氧(ROS)和凋亡水平评估线粒体的治疗效果。应用大鼠大脑中动脉闭塞模型评估体内线粒体治疗效果。进行转录组学以探索潜在机制。通过多种荧光标记方法实现线粒体命运追踪。
Neuro-2a(N2a)细胞来源的线粒体具有更高的线粒体膜电位、更活跃的氧化呼吸能力和更少的线粒体DNA拷贝数。外源性线粒体移植以氧依赖方式提高细胞活力,降低ROS和凋亡水平,改善神经行为缺陷,并减小梗死体积。转录组学数据显示差异基因富集途径与代谢相关,尤其是脂质代谢。线粒体追踪表明外源性线粒体的特定部分与宿主细胞的线粒体融合,其他部分则被溶酶体摄取。此过程发生在内化开始时,其效率与细胞间连接有关。
线粒体移植可能减轻脑I/R损伤。其机制可能与线粒体成分分离、改变细胞代谢、以氧依赖方式减少ROS和凋亡有关。分离的线粒体进入细胞的方式可能与细胞间连接有关。